Tested Applications
| Positive IHC detected in | human lung cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11600-1-AP targets HCK in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2132 Product name: Recombinant human HCK protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 221-526 aa of BC014435 Sequence: ELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP Predict reactive species |
| Full Name | hemopoietic cell kinase |
| Calculated Molecular Weight | 57 kDa |
| Observed Molecular Weight | 57 kDa |
| GenBank Accession Number | BC014435 |
| Gene Symbol | HCK |
| Gene ID (NCBI) | 3055 |
| RRID | AB_10640577 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P08631 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for HCK antibody 11600-1-AP | Download protocol |
| WB protocol for HCK antibody 11600-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Anti-HCK (Hematopoietic Cell Kinase) antibody (Cat# 11600-1-AP) has 8 citations published in Cell Communications & Signaling, Molecular Therapy, Journal of Hazardous Materials, Frontiers in Pharmacology, Food Science & Nutrition, Immunity Inflammation & Disease, Frontiers in Cardiovascular Medicine, and Frontiers in Genetics. Research fields span neuroinflammation after traumatic brain injury, tumor immunotherapy in TNBC, pulmonary silica nanoparticle injury, NLRP3 inflammasome activation, bladder cancer ferroptosis, diabetic nephropathy, atherosclerosis, and IgA nephropathy.
| Species | Application | Title |
|---|---|---|
Cell Commun Signal Hematopoietic cell kinase regulates microglial/macrophage activation to drive neuroinflammation after traumatic brain injury. | ||
Mol Ther DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8(+) T cell immunity in TNBC.
| ||
J Hazard Mater Immune activation contributes recovery following pulmonary impairments by silica nanoparticles | ||
Front Pharmacol Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo.
| ||
Food Sci Nutr Dauricine Inhibits Macrophages M2 Polarization and Regulates the Progression and Ferroptosis via HCK/IDO1 in Urinary Bladder Cancer. | ||
Immun Inflamm Dis Characterization of NLRP3 Inflammasome-Associated Hub Genes in the Progression of Diabetic Nephropathy. |



